N. Esther Babady

6.5k total citations
113 papers, 3.1k citations indexed

About

N. Esther Babady is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, N. Esther Babady has authored 113 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 57 papers in Epidemiology and 20 papers in Oncology. Recurrent topics in N. Esther Babady's work include Viral gastroenteritis research and epidemiology (21 papers), Antifungal resistance and susceptibility (20 papers) and Bacterial Identification and Susceptibility Testing (18 papers). N. Esther Babady is often cited by papers focused on Viral gastroenteritis research and epidemiology (21 papers), Antifungal resistance and susceptibility (20 papers) and Bacterial Identification and Susceptibility Testing (18 papers). N. Esther Babady collaborates with scholars based in United States, China and Ireland. N. Esther Babady's co-authors include Ngozi H. Ugochukwu, Mini Kamboj, Yi‐Wei Tang, Tracy McMillen, Jeffrey Stiles, Kent A. Sepkowitz, Edwin Miranda, Nancy L. Wengenack, Sejal Morjaria and Peter A. Mead and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

N. Esther Babady

106 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Esther Babady United States 30 1.7k 1.6k 404 293 269 113 3.1k
Jong Hee Shin South Korea 37 2.4k 1.4× 2.1k 1.4× 862 2.1× 480 1.6× 70 0.3× 233 4.5k
Robert Krause Austria 41 3.2k 1.9× 3.0k 1.9× 647 1.6× 296 1.0× 93 0.3× 164 5.4k
Frederick S. Nolte United States 32 1.5k 0.9× 2.2k 1.4× 664 1.6× 648 2.2× 58 0.2× 122 4.4k
Antonella Lupetti Italy 32 912 0.5× 877 0.6× 791 2.0× 440 1.5× 61 0.2× 100 3.1k
G. Petrikkos Greece 35 3.5k 2.1× 3.1k 2.0× 400 1.0× 300 1.0× 105 0.4× 100 5.3k
M. Montero Spain 26 508 0.3× 785 0.5× 477 1.2× 179 0.6× 186 0.7× 89 2.7k
Francesco Menichetti Italy 37 1.6k 0.9× 1.7k 1.1× 333 0.8× 704 2.4× 103 0.4× 111 4.2k
Soile Blomqvist Finland 27 1.5k 0.9× 1.5k 0.9× 352 0.9× 47 0.2× 156 0.6× 63 3.1k
Mohammad Asgharzadeh Iran 30 785 0.5× 537 0.3× 960 2.4× 227 0.8× 84 0.3× 167 3.0k
Giulia De Angelis Italy 32 1.2k 0.8× 989 0.6× 454 1.1× 862 2.9× 38 0.1× 106 3.4k

Countries citing papers authored by N. Esther Babady

Since Specialization
Citations

This map shows the geographic impact of N. Esther Babady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Esther Babady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Esther Babady more than expected).

Fields of papers citing papers by N. Esther Babady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Esther Babady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Esther Babady. The network helps show where N. Esther Babady may publish in the future.

Co-authorship network of co-authors of N. Esther Babady

This figure shows the co-authorship network connecting the top 25 collaborators of N. Esther Babady. A scholar is included among the top collaborators of N. Esther Babady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Esther Babady. N. Esther Babady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ng, Dianna, et al.. (2025). An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. Journal of Clinical Microbiology. 63(3). e0036124–e0036124. 6 indexed citations
2.
Laracy, Justin, June L. Chan, Kevin Raible, et al.. (2025). Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients. Clinical Infectious Diseases. 80(5). 969–974. 2 indexed citations
3.
4.
Morjaria, Sejal & N. Esther Babady. (2025). Maximizing the diagnostic potential of 1,3 beta-D-glucan assays for invasive fungal infections. Clinical Microbiology Newsletter. 50. 24–33. 1 indexed citations
5.
Kalchiem‐Dekel, Or, Mini Kamboj, Tobias M. Hohl, et al.. (2025). Evaluating the clinical utility of Aspergillus , Mucorales, and Nocardia bronchoalveolar PCRs for the diagnosis of invasive pulmonary infections in patients with hematological malignancies. Journal of Clinical Microbiology. 63(2). e0135524–e0135524. 1 indexed citations
6.
Wolk, Donna M., J. Scott Parrott, N. Esther Babady, et al.. (2025). The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. Clinical Microbiology Reviews. 38(3). e0013724–e0013724. 3 indexed citations
7.
Zhai, Bing, Chen Liao, Yuanyuan Tang, et al.. (2024). Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections. Nature Medicine. 30(11). 3163–3172. 24 indexed citations
8.
Aslam, Anoshé, et al.. (2024). Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer. Infection Control and Hospital Epidemiology. 45(12). 1405–1409.
9.
Laracy, Justin, Nina Cohen, Elizabeth Robilotti, et al.. (2023). Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients. Haematologica. 108(11). 3058–3067. 6 indexed citations
10.
Babady, N. Esther, et al.. (2022). Building a Resilient Scientific Network for COVID-19 and Beyond. mBio. 13(5). e0222322–e0222322. 1 indexed citations
11.
Kim, Justin, David Qualls, Madeline A. Hwee, et al.. (2022). Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses. Cancer Cell. 40(7). 738–753.e5. 32 indexed citations
12.
Laracy, Justin, Elizabeth Robilotti, Anabella Lucca Bianchi, et al.. (2022). Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant. Infection Control and Hospital Epidemiology. 44(5). 821–823. 14 indexed citations
13.
Zhai, Bing, Mihaela Ola, Thierry Rolling, et al.. (2021). Identification of a novel Candida metapsilosis isolate reveals multiple hybridization events. G3 Genes Genomes Genetics. 12(1). 10 indexed citations
14.
Kondo, Maiko, Matthew S. Simon, Lars F. Westblade, et al.. (2020). Implementation of infectious diseases rapid molecular diagnostic tests and antimicrobial stewardship program involvement in acute-care hospitals. Infection Control and Hospital Epidemiology. 42(5). 609–611. 5 indexed citations
15.
Kamboj, Mini, Jennifer Brite, Tracy McMillen, et al.. (2017). Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer. Journal of Infection. 76(4). 369–375. 38 indexed citations
16.
Otto, Caitlin, et al.. (2017). Detection of gastrointestinal pathogens in oncology patients by highly multiplexed molecular panels. European Journal of Clinical Microbiology & Infectious Diseases. 36(9). 1665–1672. 11 indexed citations
17.
Isa, Flonza, Kohta Saito, Yao-Ting Huang, et al.. (2016). Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers. Clinical Infectious Diseases. 63(4). 565–568. 19 indexed citations
18.
Richardson, Lauren, Alexander J. Chou, N. Esther Babady, et al.. (2015). Control of norovirus outbreak on a pediatric oncology unit. American Journal of Infection Control. 43(10). 1066–1069. 14 indexed citations
19.
Kaltsas, Anna, Danielle Wroblewski, Kimberlee A. Musser, et al.. (2012). Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test Results. Journal of Clinical Microbiology. 50(4). 1303–1307. 52 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong Hee Shin Breakdown of academic impact, for papers by Robert Krause Breakdown of academic impact, for papers by Frederick S. Nolte Breakdown of academic impact, for papers by Antonella Lupetti Breakdown of academic impact, for papers by G. Petrikkos Breakdown of academic impact, for papers by M. Montero Breakdown of academic impact, for papers by Francesco Menichetti Breakdown of academic impact, for papers by Soile Blomqvist Breakdown of academic impact, for papers by Mohammad Asgharzadeh Breakdown of academic impact, for papers by Giulia De Angelis
Rankless by CCL
2026